RT @DrPetryna: @RheumNow #acr21 abst 195 prospective study of JAKi for refractory Stillâs in 7 pts suggests JAKs can b
Tweet Content
@RheumNow #acr21 abst 195 prospective study of JAKi for refractory Still’s in 7 pts suggests JAKs can be useful as an add on but not in monotherapy : partial response 57%& failure in43%. No patient achieved complete remission. steroids could be decreased by63%~ https://t.co/rYHVReRHvL
Show on Archive Page
On
Display in Search Results
On
PDQ
Off